
Clopidogrel
Clopidogrel is an antiplatelet drug backed by large trials: it was modestly better than aspirin at preventing stroke, heart attack or vascular death in people with artery disease, and added to aspirin it lowered major events after acute coronary syndromes at the cost of more bleeding. Its boxed warning says it works less well in CYP2C19 poor metabolizers. Grapefruit juice is a high-severity concern in our database, and garlic and ginkgo supplements are moderate.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with acute coronary syndrome, a recent heart attack or stroke, or peripheral artery disease whose prescriber recommends clopidogrel
Common dosing range
Set by your prescriber. The Plavix label: 75 mg once daily; for acute coronary syndrome, a single 300 mg loading dose first, then 75 mg once daily with aspirin
When to expect effects
Within hours after a 300 mg loading dose; the label says starting without a loading dose delays the antiplatelet effect by several days
Watch out for
Boxed warning: less effective in people with two loss-of-function copies of the CYP2C19 gene. It raises bleeding risk, more so with NSAIDs, warfarin, other antiplatelets, SSRIs and SNRIs; stopping it early raises the risk of heart attack and stroke. The label says to avoid omeprazole and esomeprazole with it
What is it
Clopidogrel is a prescription antiplatelet medicine, a P2Y12 inhibitor, that keeps platelets from clumping into clots. It is sold as generic clopidogrel tablets and as Plavix. The Plavix label approves it to lower the rate of heart attack and stroke in people with acute coronary syndrome (unstable angina or a heart attack), given together with aspirin, and in people with a recent heart attack, a recent stroke or established peripheral artery disease.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
preventing stroke, heart attack and vascular death in artery disease (compared with aspirin) Good Evidence | Small; about 9% fewer major vascular events than aspirin | Adults with recent ischemic stroke, recent heart attack or symptomatic peripheral artery disease | Measured over a mean of 1.91 years |
acute coronary syndrome without ST elevation (with aspirin) Good Evidence | Moderate; about 20% fewer major cardiovascular events, with more major bleeding | Adults with unstable angina or non-ST-elevation heart attack also taking aspirin | Treatment lasted 3 to 12 months |
heart attack, mostly with ST elevation (with aspirin) Good Evidence | Small; about 9 fewer events per 1,000 people treated for about 2 weeks | Adults in the first day of a heart attack also taking aspirin | Measured during a mean of 15 days in hospital |
broad prevention in stable disease or multiple risk factors (with aspirin) Good Evidence | No significant reduction in the main outcome | Not applicable: the trial did not show benefit in this broad group | Measured over a median of 28 months |
preventing stroke, heart attack and vascular death in artery disease (compared with aspirin)
- Effect
- Small; about 9% fewer major vascular events than aspirin
- Best fit
- Adults with recent ischemic stroke, recent heart attack or symptomatic peripheral artery disease
- Time
- Measured over a mean of 1.91 years
acute coronary syndrome without ST elevation (with aspirin)
- Effect
- Moderate; about 20% fewer major cardiovascular events, with more major bleeding
- Best fit
- Adults with unstable angina or non-ST-elevation heart attack also taking aspirin
- Time
- Treatment lasted 3 to 12 months
heart attack, mostly with ST elevation (with aspirin)
- Effect
- Small; about 9 fewer events per 1,000 people treated for about 2 weeks
- Best fit
- Adults in the first day of a heart attack also taking aspirin
- Time
- Measured during a mean of 15 days in hospital
broad prevention in stable disease or multiple risk factors (with aspirin)
- Effect
- No significant reduction in the main outcome
- Best fit
- Not applicable: the trial did not show benefit in this broad group
- Time
- Measured over a median of 28 months
Evidence for 4 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
preventing stroke, heart attack and vascular death in artery disease (compared with aspirin)
Disease adjunctIn the blinded CAPRIE trial, 19,185 people with a recent ischemic stroke, a recent heart attack or symptomatic peripheral artery disease took clopidogrel 75 mg or aspirin 325 mg daily for 1 to 3 years (mean 1.91 years). The yearly rate of ischemic stroke, heart attack or vascular death was 5.32% on clopidogrel versus 5.83% on aspirin, a relative risk reduction of 8.7%. Intracranial bleeding (0.33% vs 0.47%) and gastrointestinal bleeding (0.52% vs 0.72%) judged severe were similar or lower.
Bottom line: Clopidogrel alone prevented slightly more strokes and heart attacks than aspirin in people with artery disease.
acute coronary syndrome without ST elevation (with aspirin)
Disease adjunctIn the CURE trial, 12,562 people seen within 24 hours of unstable angina or a non-ST-elevation heart attack took clopidogrel (300 mg, then 75 mg daily) or placebo on top of aspirin for 3 to 12 months. Cardiovascular death, heart attack or stroke occurred in 9.3% versus 11.4% (relative risk 0.80). Major bleeding rose (3.7% vs 2.7%), but life-threatening bleeding (2.2% vs 1.8%) and bleeding strokes (0.1% each) did not differ significantly.
Bottom line: Adding clopidogrel to aspirin after an acute coronary syndrome prevents more heart events, with more bleeding.
heart attack, mostly with ST elevation (with aspirin)
Disease adjunctIn the COMMIT trial, 45,852 people admitted within 24 hours of a suspected heart attack in China took clopidogrel 75 mg or placebo daily, on top of aspirin 162 mg, until discharge or for up to 4 weeks (mean 15 days). Death, repeat heart attack or stroke fell from 10.1% to 9.2% (a 9% relative reduction), and death from any cause from 8.1% to 7.5%. Fatal, transfused or brain bleeds were not significantly more common (0.58% vs 0.55%).
Bottom line: Clopidogrel added to aspirin early in a heart attack slightly lowered deaths and major events without excess serious bleeding.
broad prevention in stable disease or multiple risk factors (with aspirin)
No benefit foundIn the CHARISMA trial, 15,603 people with established cardiovascular disease or multiple risk factors took clopidogrel 75 mg or placebo on top of low-dose aspirin for a median of 28 months. Heart attack, stroke or cardiovascular death occurred in 6.8% versus 7.3%, a difference that was not significant (relative risk 0.93), while severe bleeding was 1.7% versus 1.3%. In people with risk factors only, the rate was 6.6% on clopidogrel versus 5.5% on placebo (not significant).
Bottom line: Adding clopidogrel to aspirin for broad prevention did not significantly cut heart attacks or strokes.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose; take it daily as directed, talk to your prescriber before any pause, ask about heartburn medicines (the label says to avoid omeprazole and esomeprazole), and check every supplement for bleeding risk.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: diminished antiplatelet effect in people with two loss-of-function alleles of the CYP2C19 gene (CYP2C19 poor metabolizers). Plavix works through an active metabolite made mainly by CYP2C19, and poor metabolizers make less of it. Tests can identify poor metabolizers, and the label says to consider another P2Y12 inhibitor for them. The label says about 2% of White and 4% of Black patients are poor metabolizers, with higher rates in Asian patients (for example 14% of Chinese).
Bleeding, including life-threatening and fatal bleeding. Risk rises with anticoagulants, other antiplatelet drugs and chronic NSAID use. Because affected platelets stay blocked for 7 to 10 days, the effect lasts after the last dose.
Stopping it raises the risk of cardiovascular events such as heart attack and stroke. The label says to restart as soon as possible after any interruption.
Thrombotic thrombocytopenic purpura (TTP), sometimes fatal, sometimes after less than 2 weeks of use; it needs urgent treatment. Allergic reactions can also occur, including in people who reacted to other thienopyridines.
Who should avoid it
- People with active pathological bleeding, such as a peptic ulcer or bleeding inside the skull (contraindicated)
- People with a hypersensitivity reaction, such as anaphylaxis, to clopidogrel or any ingredient of the tablet (contraindicated)
- Known CYP2C19 poor metabolizers, for whom the label says to consider another P2Y12 inhibitor
Pregnancy & breastfeeding
Pregnancy: the Plavix label says published case reports and postmarketing data have not identified a drug-associated risk of major birth defects or miscarriage, that a heart attack or stroke in pregnancy is an emergency and treatment should not be withheld over concerns about the fetus, and that clopidogrel during labor or delivery increases the risk of maternal bleeding; when possible it is stopped 5 to 7 days before labor, delivery or spinal or epidural anesthesia. Breastfeeding: the label says there are no data on clopidogrel in human milk or on milk production, no adverse effects on breastfed infants were seen in a small number of postmarketing cases, and it is found in rat milk; it says to weigh the benefits of breastfeeding against the mother's need for treatment. Discuss pregnancy and breastfeeding plans with your doctor.
Interactions
The Plavix label says to avoid these heartburn medicines with clopidogrel because they block CYP2C19 and significantly reduce its antiplatelet effect, even when omeprazole was taken 12 hours apart. It says dexlansoprazole, lansoprazole and pantoprazole had less effect. Ask your prescriber or pharmacist before taking any heartburn medicine, including over-the-counter ones.
The Plavix label says NSAIDs increase the risk of stomach and intestinal bleeding with clopidogrel, warfarin and other antiplatelet drugs add to bleeding risk, and SSRI and SNRI antidepressants may too. Aspirin is part of the prescribed regimen for some uses, but ask your pharmacist before using any over-the-counter pain reliever.
A clopidogrel metabolite strongly blocks the enzyme CYP2C8, and the Plavix label says clopidogrel raised exposure to the diabetes medicine repaglinide 3.9-fold to 5.1-fold. The label says to avoid the combination, or, if it cannot be avoided, to use a lower repaglinide dose with closer glucose monitoring. Your prescriber decides.
Clopidogrel must be activated by enzymes including CYP2C19 and CYP3A4, which grapefruit juice inhibits. In a crossover study in 14 healthy volunteers, grapefruit juice cut the peak level of clopidogrel's active metabolite to 13% of normal, and the authors advised avoiding grapefruit juice during clopidogrel therapy; a second small study found a significantly weaker platelet effect after a loading dose but no significant difference during daily dosing. The risk is less protection against clots, not more bleeding. Avoid grapefruit, and never stop or change clopidogrel on your own.
Garlic compounds can make platelets less sticky, so concentrated garlic supplements may add to clopidogrel's bleeding risk. In a randomized trial in 34 healthy adults taking no antiplatelet drug, aged garlic extract at 2.4 to 7.2 g a day moderately raised the threshold for platelet clumping with some triggers and reduced platelet sticking to vessel-wall proteins, while in another study 4.2 g of raw garlic in a meal did not impair platelet function in 18 healthy volunteers. Neither study gave clopidogrel, and no study has tested garlic with clopidogrel. Tell your prescriber and pharmacist about any garlic supplement, especially before surgery or a procedure; garlic in food is not the concern.
Ginkgo affects platelets through a different pathway from clopidogrel. In a small open-label crossover study in 10 healthy men, a single dose of ginkgo 120 mg with clopidogrel 75 mg did not increase platelet inhibition beyond clopidogrel alone 6 hours later. In a hospital records study in Vietnam of patients prescribed ginkgo extract, clopidogrel was among the co-prescribed drugs significantly associated with bleeding and abnormal clotting tests, an association that does not prove cause. Ask your prescriber or pharmacist before combining them, and mention ginkgo before any surgery or procedure.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (3)
+ grapefruit
highClopidogrel is a prodrug: liver and gut enzymes, including CYP2C19 and CYP3A4, turn it into the active form that stops platelets from clumping. In a crossover study in 14 healthy volunteers, grapefruit juice cut the peak level of clopidogrel's active metabolite to 13% of normal, and the authors concluded grapefruit juice is best avoided during clopidogrel therapy. A second small study in healthy volunteers found a significantly weaker platelet effect after a loading dose taken with grapefruit juice, but no significant difference during daily dosing, and its authors called the evidence insufficient for a firm conclusion.
+ garlic
moderateClopidogrel blocks the platelet P2Y12 ADP receptor to prevent clots. Concentrated garlic supplements may also make platelets less sticky: in a trial in 34 healthy adults, aged garlic extract at 2.4 to 7.2 g a day moderately inhibited platelet clumping and adhesion, while 4.2 g of raw garlic in a meal did not impair platelet function in 18 volunteers. No study has tested garlic with clopidogrel, so any added bleeding risk is predicted from mechanism. Culinary garlic in food amounts is not a meaningful concern.
+ ginkgo
moderateClopidogrel blocks the platelet P2Y12 ADP receptor, while ginkgo acts on platelets through a separate pathway. In a small open-label study in 10 healthy men, a single dose of ginkgo with clopidogrel did not increase platelet inhibition beyond clopidogrel alone 6 hours later. In a hospital records study of patients prescribed ginkgo extract, clopidogrel was among the co-prescribed drugs associated with bleeding and abnormal clotting tests, an association that does not prove cause, and case reports describe bleeding with ginkgo alone. The realistic concern is a modest, additive bleeding risk, most relevant in older patients and those also taking aspirin.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take garlic supplements with clopidogrel?⌄
This page rates concentrated garlic supplements a moderate-severity interaction. Aged garlic extract reduced platelet stickiness in healthy adults, so it may add to bleeding risk, although no study has tested it with clopidogrel. Garlic in food did not affect platelets in a small study. Tell your prescriber and pharmacist about any garlic supplement, especially before a procedure.
Is ginkgo safe with clopidogrel?⌄
This page rates ginkgo a moderate-severity interaction. A small single-dose study in healthy men found no extra platelet effect, but hospital records linked ginkgo plus clopidogrel to bleeding and abnormal clotting tests. Ask your prescriber or pharmacist before combining them.
Can I take omeprazole or other heartburn medicines with clopidogrel?⌄
The Plavix label says to avoid omeprazole and esomeprazole because they significantly reduce clopidogrel's effect. It says lansoprazole, dexlansoprazole and pantoprazole had less effect. Ask your prescriber or pharmacist which heartburn treatment is right for you.
What does the CYP2C19 warning mean?⌄
Clopidogrel has to be activated by the liver enzyme CYP2C19. People born with two non-working copies of the gene make less of the active form, so the drug protects them less. A test can identify them, and the label says to consider another antiplatelet drug. Ask your prescriber whether testing applies to you.
Should I stop clopidogrel before surgery or dental work?⌄
Only if your prescriber or surgeon tells you to. The label says stopping raises the risk of heart attack and stroke, and when a pause is needed for surgery with a major bleeding risk it describes stopping 5 days before and restarting as soon as bleeding is controlled. They will plan this with you.
References by claim
preventing stroke, heart attack and vascular death in artery disease (compared with aspirin)
CAPRIE Steering Committee et al., 1996 · PubMed (1996) link
acute coronary syndrome without ST elevation (with aspirin)
Yusuf et al., 2001 · PubMed (2001) link
heart attack, mostly with ST elevation (with aspirin)
Chen et al., 2005 · PubMed (2005) link
broad prevention in stable disease or multiple risk factors (with aspirin)
Bhatt et al., 2006 · PubMed (2006) link
Safety
Plavix (clopidogrel) prescribing information · DailyMed (FDA label) link
Interaction: Garlic (concentrated supplements)
Track Clopidogrel with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
